T. Salman Et Al. , "Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study," CHEMOTHERAPY , vol.61, no.6, pp.281-286, 2015
Salman, T. Et Al. 2015. Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study. CHEMOTHERAPY , vol.61, no.6 , 281-286.
Salman, T., KAZAZ, S. N., Varol, U., Oflazoglu, U., ÜNEK, İ. T., KÜÇÜKZEYBEK, Y., ... ALACACIOĞLU, A.(2015). Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study. CHEMOTHERAPY , vol.61, no.6, 281-286.
Salman, Tarik Et Al. "Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study," CHEMOTHERAPY , vol.61, no.6, 281-286, 2015
Salman, Tarik Et Al. "Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study." CHEMOTHERAPY , vol.61, no.6, pp.281-286, 2015
Salman, T. Et Al. (2015) . "Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study." CHEMOTHERAPY , vol.61, no.6, pp.281-286.
@article{article, author={Tarik Salman Et Al. }, title={Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study}, journal={CHEMOTHERAPY}, year=2015, pages={281-286} }